Northern Trust Corp P Lx Pharma Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.9 - $4.18 $10,716 - $23,575	-5,640 Reduced 12.02%	41,285 $100,000
Q1 2022 May 13, 2022	SELL	$3.54 - $8.3 $5,440 - $12,757	-1,537 Reduced 3.17%	46,925 $190,000
Q4 2021 Feb 08, 2022	BUY	$7.69 - $19.66 $43,010 - $109,958	5,593 Added 13.05%	48,462 $388,000
Q3 2021 Nov 15, 2021	SELL	$12.22 - $21.28 $20,089 - $34,984	-1,644 Reduced 3.69%	42,869 $827,000
Q2 2021 Aug 13, 2021	BUY	$9.0 - $15.94 $77,229 - $136,781	8,581 Added 23.88%	44,513 $614,000

Q1 2021 May 12, 2021	BUY	$5.24 - $10.14 $135,658 - $262,514	25,889 Added 257.78%	35,932 $324,000
Q4 2020 Feb 11, 2021	BUY	$3.01 - $6.7 $30,229 - $67,288	10,043 New	10,043 $55,000
Q2 2020 Aug 14, 2020	SELL	$2.32 - $4.02 $25,473 - $44,139	-10,980 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.36 - $5.04 $77 - $115	-23 Reduced 0.21%	10,980 $48,000
Q3 2019 Nov 13, 2019	SELL	$4.89 - $7.18 $488 - $718	-100 Reduced 0.9%	11,003 $57,000
Q1 2019 May 13, 2019	BUY	$2.05 - $6.0 $22,761 - $66,618	11,103 New	11,103 $59,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.